Highlights

Good Articles to Share

Author: Tan KW   |   Latest post: Fri, 23 Oct 2020, 12:21 AM

 

Pharma & DPharma: Some Inconvenient Questions - Alex Lu

Author:   |    Publish date:


Thursday, July 23, 2020

 
In the past 2 days, we have been witnessing spectacular rallies for 2 pharmaceutical stocks, Pharma and DPharma. What prompted the rally was an announcement on July 14 by the Science, Technology & Innovation Minister, Khairy that Pharma and DPharma will do the "fill-and-finish" process for the re-packing the Covid-19 vaccine when it becomes available (here).
 
We know that the market is getting wary of glove stocks after the spectacular rally, and many players are now looking for something else to play. So the above story seems like just the right catalyst to shift to new stocks that are (1) relatively inexpensive vis-a-vis the glove stocks and (2) they can still be counted as pandemic stocks. 
 
However, there are a few inconvenient questions which we must answer if and when we want to get into Pharma and DPharma. They are:
 
1) When will the vaccine be available? Despite promising progress made, the first vaccine will be at least 18 months from now. That's the optimistic case!
 
2) Will the vaccine be produced in sufficient quantity to reach our shore? This is a tough one. The answer is probably not for a few years as demand will continue to outstrip supply, and America- the epicenter of the pandemic- has shown that it is willing to use its enormous muscle to buy up everything.
 
3) Can Pharma and DPharma handle the fill-and-finish process? While they may have done similar process for other drugs or vaccines, the new vaccine for Covid-19 will be novel and involve complex chemistry. They may need special pharmaceutical-grade glass to be bottled in. This is taken from an interview given by Bill Gates in the Vox magazine back in April (here). When asked by the interviewer, Ezra Klein about how much of a limiting factor will the manufacturing supply chain capacity be, Bill Gates replied:
For some of these vaccine constructs, it’s hard to scale up the manufacturing, partly because they are novel or just because the chemistry is very complex. And you’re in a new regime when you talk about making billions of a vaccine. We don’t make billions of any vaccine. We make hundreds of millions, but for those, we’ve had decades to work on their efficiency.
Even the fill finish at the very end where you put it in a glass bottle, that’s a special pharmaceutical-grade glass — the world doesn’t have enough of that. So we’re working to get that underway because all the vaccine approaches need to be put into a bottle at some point in time. I hope we get to the point where it’s the manufacturing piece because those investments are at most billions to save trillions.
4) Where is the market for the end-product, the re-bottled vaccine? If it is for the local market, then that market is too small for the time and effort required to get into the business. I presume it would include overseas market, such as Indonesia etc. I remember our pharmaceutical companies needed a long time to apply for licenses to distribute individual drugs in Indonesia. I think the same should continue now and this will delay the business.  
 

Chart 1: Pharma's weekly chart as at July 23, 2020_9.30am (Source: Malaysiastock.biz)
 

Chart 2: DPharma's weekly chart as at July 23, 2020_9.30am (Source: Malaysiastock.biz)

All in all, I think we have to temper our enthusiasm to get into Pharma and DPharma as well as other pharmaceutical stocks which have gone up substantially. The investment basis may be comparable in some way to glove stocks, since they are deemed to be pandemic stocks, but the case for pharmaceutical stocks is very weak, unlike glove stocks. Be careful!

 
 
 

 

Share this
Labels: PHARMA, DPHARMA

Related Stocks

Chart Stock Name Last Change Volume 
PHARMA 5.32 +0.02 (0.38%) 960,000 
DPHARMA 4.01 +0.02 (0.50%) 7,303,500 

  2 people like this.
 
calvintaneng Blog: BE CAREFUL OF COVID 19 VACCINES TRIGGERED MAD COW FEVER (NOT BULL RUN LAH) SEE THE MOST IMPORTANT WARNINGS

Jul 23, 2020 10:55 AM | Report Abuse

Thks sayang

Look at the Bigger picture

Vaccines market in Malaysia

Total 32 million people

Medical gloves world wide demand

Total 7.8 billions people

If shrink down the figure to SEE CLEARER

32 PEOPLE (MINUS ONE MILLION BEHIND)

7,800 PEOPLE (MINUS ONE MILLION )

NOW IF YOU GO FISHING IN A PONDS

YOU PREFER TO FISH IN A POND WITH ONLY 32 FISHES

OR IN A POND STOCKED WITH 7,800 FISHES?

IMAGINE 1,000 PEOPLE RUSH TO FISH IN A POND WITH ONLY 32 FISHES

MANY WILL END UP DISAPPOINTED EVENTUALLY

NOW PHARMANIA MAD COW FEVER ON

WAIT TILL ALL WAKE UP LATER
23/07/2020 11:31 AM
AdamK733 I try to warn investors.....but instead kena diu. LOL.

Do you take vaccine everyday? every week? every year? or just need 1 injection?

it might be a 1 time off business only. Not a continuous business like selling panadol.

Is Pharma & Dpharma selling to whole world now after packaging? LOL

Not to mention, any business dealing with government.....they need to put aside "some" margin....for pocket money. Better I dont go into this, later kena jailed. Hahaha. End up....profit....dam thin.
23/07/2020 1:40 PM
Ravi Kumar Question is why should the big drug companies would need Pharmaniaga and other Malaysian players. They will want to maximize their profits.
23/07/2020 6:12 PM
Jokers2020 bcos of kyy write out today price drop..will be curse by many ..
23/07/2020 6:23 PM
Gala Kat Cursed by silly or naïve fools ... you mean ?
24/07/2020 12:37 PM
lcwin yep this 2 cpy are milk cow for the cronies...putting label also got problem one hehehe but no problem screwing the rakyat
24/07/2020 4:08 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

464  492  569  640 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LAMBO 0.030.00 
 DGSB 0.185-0.045 
 IRIS 0.305+0.04 
 MLAB 0.0250.00 
 KGROUP-OR 0.01+0.005 
 MAHSING 1.14+0.01 
 DSONIC 0.585+0.06 
 AT 0.08-0.005 
 KGROUP 0.065+0.005 
 LUSTER 0.19-0.005 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS